RAPP NASDAQ
Rapport Therapeutics, Inc. Common Stock
1W: -5.1%
1M: -33.9%
3M: -16.6%
YTD: +14.4%
1Y: +12.2%
$32.17
-0.66 (-2.01%)
Weekly Expected Move ±9.7%
$26
$29
$32
$35
$38
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$20M
Revenue
+0.0% YoY
$-137M
Net Income
-55.3% YoY
$-97M
Free Cash Flow
-26.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-40.0%
ROA-36.8%
ROIC3981.5%
Valuation
P/E-10.6
P/B3.6
EV/EBITDA-10.7
Leverage
Debt/Equity0.02
Current Ratio15.72
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z32.05
Beneish M0.00